Italian Prospective Data Collection for Better Patient Characterization in a Highly Treatment Experienced Population
1 other identifier
observational
428
1 country
21
Brief Summary
Data collection for better patient characterization in a highly treatment experienced population. Studying the clinical practice for the treatment of HIV multiexperienced patients in the real life. The research will be divided into two phases:
- The first phase intends to define and understand the clinical practice using a questionnaire about general topics: definitions of multiexperienced patients and VL failure, therapeutic strategies and behaviour in particular cases.
- The second part of the research will collect the clinical data of double PIs failure patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
21 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2007
CompletedFirst Submitted
Initial submission to the registry
January 31, 2008
CompletedFirst Posted
Study publicly available on registry
February 13, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2008
CompletedOctober 2, 2009
October 1, 2009
1.3 years
January 31, 2008
October 1, 2009
Conditions
Outcome Measures
Primary Outcomes (1)
To study in the clinical practice the choice of a specific salvage regimen for multiexperienced patients.
48 weeks
Secondary Outcomes (1)
Reason of each VL failure or switching
48 weeks
Interventions
Eligibility Criteria
HIV patients
You may qualify if:
- Patients double PIs failure
You may not qualify if:
- Not Applicable
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (21)
Boehringer Ingelheim Investigational Site
Ancona, Italy
Boehringer Ingelheim Investigational Site
Bari, Italy
Boehringer Ingelheim Investigational Site
Benevento, Italy
Boehringer Ingelheim Investigational Site
Bisceglie, Italy
Boehringer Ingelheim Investigational Site
Bologna, Italy
Boehringer Ingelheim Investigational Site
Brescia, Italy
Boehringer Ingelheim Investigational Site
Busto, Italy
Boehringer Ingelheim Investigational Site
Caserta, Italy
Boehringer Ingelheim Investigational Site
Catania, Italy
Boehringer Ingelheim Investigational Site
Cremona, Italy
Boehringer Ingelheim Investigational Site
Florence, Italy
Boehringer Ingelheim Investigational Site
Genova, Italy
Boehringer Ingelheim Investigational Site
Legnano, Italy
Boehringer Ingelheim Investigational Site
Milan, Italy
Boehringer Ingelheim Investigational Site
Napoli, Italy
Boehringer Ingelheim Investigational Site
Padua, Italy
Boehringer Ingelheim Investigational Site
Palermo, Italy
Boehringer Ingelheim Investigational Site
Pavia, Italy
Boehringer Ingelheim Investigational Site
Roma, Italy
Boehringer Ingelheim Investigational Site
Sassari, Italy
Boehringer Ingelheim Investigational Site
Torino, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Boehringer Ingelheim
Boehringer Ingelheim
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
January 31, 2008
First Posted
February 13, 2008
Study Start
June 1, 2007
Primary Completion
October 1, 2008
Last Updated
October 2, 2009
Record last verified: 2009-10